Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Speed, Joshua S ^a,b   George, Eric M ^a,b   Arany, Marietta ^a,b   Cockrell, Kathy ^a,b   Granger, Joey P ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ARACHIDONIC ACID; CYTOCHROME P450 4A1; ENDOTHELIN B RECEPTOR ANTAGONIST; NATRIURETIC FACTOR; SODIUM; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ENDOTHELIN B RECEPTOR; HYDROXYICOSATETRAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HYPERTENSION; KIDNEY MEDULLA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RECEPTOR BLOCKING; SODIUM EXCRETION; SODIUM INTAKE; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; SALT INTAKE; SPRAGUE DAWLEY RAT; TIME;

RATTUS;

ANIMALS; BLOOD PRESSURE; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; KIDNEY MEDULLA; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; SODIUM CHLORIDE, DIETARY; TIME FACTORS;

EID: 80053917877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026063     Document Type: Article

References (23)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
2. Mortensen LH, Pawloski CM, Kanagy NL, Fink GD, (1990) Chronic hypertension produced by infusion of endothelin in rats. Hypertension 15: 729-733.
3. Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, et al. (1996) Differential regulation of renal regional blood flow by endothelin-1. Am J Physiol 271: F1166-1172.
4. Kitamura K, Tanaka T, Kato J, Eto T, Tanaka K, (1989) Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem Biophys Res Commun 161: 348-352.
5. Plato CF, Pollock DM, Garvin JL, (2000) Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release. Am J Physiol Renal Physiol 279: F326-333.
6. Herrera M, Hong NJ, Ortiz PA, Garvin JL, (2009) Endothelin-1 inhibits thick ascending limb transport via Akt-stimulated nitric oxide production. J Biol Chem 284: 1454-1460.
7. Pavlov TS, Chahdi A, Ilatovskaya DV, Levchenko V, Vandewalle A, et al. (2010) Endothelin-1 inhibits the epithelial Na+ channel through betaPix/14-3-3/Nedd4-2. J Am Soc Nephrol 21: 833-843.
8. Pollock DM, Pollock JS, (2001) Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 281: F144-150.
9. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, et al. (2004) Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504-511.
10. Hoffman A, Grossman E, Goldstein DS, Gill JR Jr, Keiser HR, (1994) Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int 45: 556-560.
11. Elijovich F, Laffer CL, (2002) Participation of renal and circulating endothelin in salt-sensitive essential hypertension. J Hum Hypertens 16: 459-467.
12. Schneider MP, Ge Y, Pollock DM, Pollock JS, Kohan DE, (2008) Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide. Hypertension 51: 1605-1610.
13. Nakano D, Pollock JS, Pollock DM, (2008) Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Am J Physiol Renal Physiol 294: F1205-1211.
14. Roman RJ, (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185.
15. Hoagland KM, Flasch AK, Roman RJ, (2003) Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 42: 669-673.
16. Stec DE, Mattson DL, Roman RJ, (1997) Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Hypertension 29: 315-319.
17. Yu M, Lopez B, Dos Santos EA, Falck JR, Roman RJ, (2007) Effects of 20-HETE on Na+ transport and Na+-K+-ATPase activity in the thick ascending loop of Henle. Am J Physiol Regul Integr Comp Physiol 292: R2400-2405.
18. Escalante BA, McGiff JC, Oyekan AO, (2002) Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule. Am J Physiol Renal Physiol 282: F144-150.
19. Williams JM, Zhao X, Wang MH, Imig JD, Pollock DM, (2005) Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade. Hypertension 46: 366-371.
20. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M, (2000) Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933.
21. Hsieh TJ, Lin SR, Lee YJ, Shin SJ, Lai YH, et al. (2000) Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats. Am J Physiol Renal Physiol 279: F112-121.
22. Wessale JL, Adler AL, Novosad EI, Calzadilla SV, Dayton BD, et al. (2002) Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies. Clin Sci (Lond) 103 (Suppl 48): 112S-117S.
23. Maier KG, Henderson L, Narayanan J, Alonso-Galicia M, Falck JR, et al. (2000) Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 279: H863-871.